Codexis (CDXS) has disclosed a new risk, in the Capital Markets category.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Codexis faces significant business risks due to international trade policies, including tariffs, sanctions, and trade barriers, which could adversely impact its operations. The global economy’s inherent uncertainties, coupled with recent U.S. government tariffs and retaliatory measures by foreign governments, pose challenges to Codexis’s supply chain and cost structure. These developments may increase research and development expenses, disrupt supply chains, and place Codexis at a competitive disadvantage compared to companies in regions with more favorable trade relationships. The ongoing uncertainty in international trade policies could materially affect Codexis’s business, financial condition, and competitive position.
Overall, Wall Street has a Strong Buy consensus rating on CDXS stock based on 4 Buys and 1 Hold.
To learn more about Codexis’ risk factors, click here.